7 completed, 5 recruiting, 4 not yet recruiting, 3 terminated. 7 Phase 2, 4 Phase 3, 2 Not applicable, 2 Phase 1, 2 Phase 4.
Follow Gastric Neoplasms: new trials by email Literature Review of Gastric Neoplasms trials Research Report on Gastric Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric Cancer: A Prospective Cohort Study Ferrous succinate, Ferrous Sulfate, Serplulimab - Gastric Neoplasms | Phase 2 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 54 | 2026-09-01 | 2026-10-14 |
| Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor Trastuzumab Rezetecan - Solid Tumors, Neoplasms (Cancer / Tumors) | Phase 2 | Not yet recruiting | Haihua Yuan | 15 | 2026-06-15 | 2026-06-08 |
| Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia | Phase 4 | Not yet recruiting | LanZhou University | 120 | 2026-04-20 | 2026-03-23 |
| Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies Helicobacter Pylori detection - Stomach Neoplasms, Gastric Neoplasms | Recruiting | University Hospital Center of Martinique | 112 | 2025-10-09 | 2026-03-31 | |
| Epinephrine 1:100,000 Versus 1:500,000 During Gastric Endoscopic Submucosal Dissection Epinephrine 1:100,000, Epinephrine 1:500,000 - Gastric Neoplasms, Gastric Dysplasia | Not applicable | Recruiting | Unidade Local de Saúde do Alto Ave, EPE | 100 | 2025-07-30 | 2026-11-05 |
| Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors vvDD-hIL-2-RG-1 - Gastric Neoplasms, Esophageal Cancer | Phase 1 | Recruiting | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 18 | 2025-05-06 | 2025-06-03 |
| Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios AI-integrated Capsule Gastroscopy (ACG) examination, Electronic gastroduodenoscopy (EGD) examination - Gastric Lesion, Gastritis | Not applicable | Completed | Nanfang Hospital, Southern Medical University | 482 | 2025-04-03 | 2026-10-26 |
| Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers Cellvizio (Registered trademark) Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes, Olympus Graphics Interchange Format (GIF) 190 endoscope, Gastric mucosal biopsy - Gastric Cancer, Gastric Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 195 | 2023-06-22 | 2025-01-17 |
| Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Camrelizumab, Pyrotinib, Capecitabine - Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Unknown | Fudan University | 65 | 2021-12-31 | 2021-11-08 |
| A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers Zanidatamab, Tislelizumab, Trastuzumab - Gastric Neoplasms, Gastroesophageal Adenocarcinoma | Phase 3 | Active not recruiting | Jazz Pharmaceuticals | 920 | 2021-12-02 | 2026-10-20 |
| The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer Identification of risk factors, Characterization of premalignant gastric lesions, Identification of biomarkers - Gastric Neoplasms, Gastric Cancer | Recruiting | EDUARDO ALBENIZ | 1200 | 2021-09-09 | 2026-10-21 | |
| Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) - Gastric Neoplasms | Phase 2 | Withdrawn | University Hospital Tuebingen | 2019-11-01 | 2025-04-03 | |
| Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome Endoscope+Cellvizio(R) 100 microscope - Gastric Cancer, Gastric Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 37 | 2019-02-11 | 2021-07-12 |
| Chromogranin A as Blood Marker in Cancer Patients BRAHMS CgA II KRYPTOR - Gastric Neoplasms, Pancreatic Neoplasms | Completed | Brahms AG | 175 | 2019-01-29 | 2022-12-20 | |
| Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) Pembrolizumab, Placebo, Cisplatin - Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma | Phase 3 | Completed | Merck Sharp & Dohme LLC | 738 | 2018-10-05 | 2026-08-26 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice Provider determined - Neoplasms, Lung Neoplasms | Terminated | CureOne | 23 | 2017-10-02 | 2019-04-02 | |
| Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063) Pembrolizumab, Paclitaxel - Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 94 | 2017-02-16 | 2023-03-30 |
| Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST) GERDX(TM) - Gastric Neoplasms, Gastrointestinal Stromal Tumors | Terminated | Kliniken Ludwigsburg-Bietigheim gGmbH | 5 | 2015-03-01 | 2016-12-09 | |
| Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer Colorectal Neoplasms, Gastric Neoplasms | Recruiting | National Cancer Institute (NCI) | 1800 | 2013-07-21 | 2026-10-29 |
Showing 20 of 23. Sign in to see all of them.
Stomach Neoplasms (23) · Pancreatic Neoplasms (5) · Colorectal Neoplasms (3) · Neoplasms (3) · Parkinson Disease 4, Autosomal Dominant Lewy Body (3) · Uterine Cervical Neoplasms (3) · Biliary Tract Neoplasms (2) · Disease (2) · Endometrial Neoplasms (2) · Esophageal Neoplasms (2) · Head and Neck Neoplasms (2) · Liver Neoplasms (2) · Stomach Ulcer (2) · Adenocarcinoma Of Esophagus (1) · Anus Neoplasms (1)
Digestive System Diseases (23) · Digestive System Neoplasms (23) · Gastrointestinal Neoplasms (23) · Neoplasms by Site (23) · Stomach Diseases (23) · Gastrointestinal Diseases (22) · Neoplasms (20) · Intestinal Diseases (6) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Neoplasms by Histologic Type (5) · Pancreatic Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Colonic Diseases (4)
Oxaliplatin (5) · Capecitabine (4) · Cisplatin (3) · Fluorouracil (3) · pembrolizumab (3) · Paclitaxel (2) · S 1 (combination) (2) · Trastuzumab (2) · ASG-5ME (1) · Brachytherapy (1) · Endoscopy, Digestive System (1) · Epinephrine (1) · Esomeprazole (1) · Gastroscopy (1) · Gemcitabine (1)
Merck Sharp & Dohme LLC (3) · National Cancer Institute (NCI) (3) · ASLAN Pharmaceuticals (1) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · Brahms AG (1) · CureOne (1) · EDUARDO ALBENIZ (1) · Fudan University (1) · Haihua Yuan (1) · Jazz Pharmaceuticals (1) · Kliniken Ludwigsburg-Bietigheim gGmbH (1) · Kosin University Gospel Hospital (1) · LanZhou University (1) · Nanfang Hospital, Southern Medical University (1) · Seagen Inc. (1)
United States (8) · China (7) · Germany (5) · South Korea (5) · Italy (3) · Spain (3) · Australia (2) · Brazil (2) · Chile (2) · France (2) · Guatemala (2) · Ireland (2) · Japan (2) · Malaysia (2) · Poland (2)
Andrew Blakely, M.D. (1) · Dane J. Dickson, M.D. (1) · Daniel M Halperin, MD (1) · Jeremy L Davis, M.D. (1) · John Pfeifer, M.D., Ph.D. (1) · Jonathan M Hernandez, M.D. (1) · Karel Caca, Prof. Dr. (1) · Mariana Souto, MD (1) · Nancy Whiting, PharmD, BCOP (1) · Patrick Wagner, MD (1) · Razelle Kurzrock, M.D. (1) · Seock-Ah Im, Dr. (1)
PMID 19097774, PMID 24714327, PMID 27397702, PMID 31183189, PMID 31483889, PMID 33167735, PMID 34012620, PMID 34197702, PMID 34878659, PMID 34912120, PMID 36000541, PMID 36342574, PMID 37871604, PMID 38238541, PMID 38424039, PMID 39282917, PMID 39453770, PMID 40341124, PMID 40354232, PMID 41324998, PMID 42202319
2023 (2), 2018 (1)